# Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer

> **NCT00587145** · PHASE2 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 44 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** S-1,Docetaxel

## Key facts

- **NCT ID:** NCT00587145
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** 2009-03
- **Final completion:** 2009-05
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2008-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00587145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00587145, "Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00587145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*